top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Caroline F. Van Hove net worth and biography

Caroline Van Hove Biography and Net Worth

Chairman of Sientra

Caroline Van Hove joined Sientra’s Board in January 2020 and was named Executive Chair in November 2020. Ms. Van Hove is a global commercial leader with over 20 years of diverse experience in the pharmaceutical, consumer and medical device industry. Her experience spans North America to Europe, Africa, the Middle East to Asia Pacific and Latin America.

Ms. Van Hove is currently President and CEO of a venture-backed, clinical-stage medical aesthetics company, and previously held several commercial leadership roles at both start-up and large-cap companies. Ms. Van Hove previously served as Chief Commercial Officer of Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on therapies in immunology and inflammation. Prior to Sienna, Ms. Van Hove was Senior Vice President of International Strategic Marketing at Allergan, where she oversaw commercial operations for the medical aesthetics, eye care and specialty care franchises. Previously, Ms. Van Hove managed sales & marketing, customer service and customer excellence in Europe, Africa and the Middle East and led Allergan’s international medical aesthetics operations. Ms. Van Hove also served as part of Allergan’s Global Operations & International Leadership Teams.

Ms. Van Hove also serves on the Board of Directors of Mission Plasticos, a global non-profit dedicated to providing reconstructive surgery to children in need.

What is Caroline F. Van Hove's net worth?: The estimated net worth of Caroline F. Van Hove is at least $0.00 as of January 13th, 2021. Ms. Van Hove owns 14,201 shares of Sientra stock worth more than $0 as of April 24th. This net worth estimate does not reflect any other investments that Ms. Van Hove may own. Additionally, Ms. Van Hove receives an annual salary of $197,740.00 as Chairman at Sientra. Learn More about Caroline F. Van Hove's net worth.
How old is Caroline F. Van Hove?: Ms. Van Hove is currently 43 years old. There are 5 older executives and no younger executives at Sientra. The oldest executive at Sientra is Mr. Keith J. Sullivan, Director & Advisor to MiraDry Business, who is 66 years old. Learn More on Caroline F. Van Hove's age.
What is Caroline F. Van Hove's salary?: As the Chairman of Sientra, Inc., Ms. Van Hove earns $197,740.00 per year. There are 3 executives that earn more than Ms. Van Hove. The highest earning executive at Sientra is Mr. Ronald Menezes, President, CEO & Director, who commands a salary of $501,180.00 per year. Learn More on Caroline F. Van Hove's salary.
How do I contact Caroline F. Van Hove?: The corporate mailing address for Ms. Van Hove and other Sientra executives is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. Sientra can also be reached via phone at (805) 562-3500 and via email at [email protected]. Learn More on Caroline F. Van Hove's contact information.
Has Caroline F. Van Hove been buying or selling shares of Sientra?: Caroline F. Van Hove has not been actively trading shares of Sientra during the last quarter. Most recently, Hove Caroline F. Van sold 608 shares of the business's stock in a transaction on Wednesday, November 10th. The shares were sold at an average price of $56.70, for a transaction totalling $34,473.60. Learn More on Caroline F. Van Hove's trading history.
Who are Sientra's active insiders?: Sientra's insider roster includes Oliver Bennett (Insider), Ronald Menezes (CEO), Valerie Miller (CFO), Andrew Schmidt (CFO), and Caroline Van Hove (Chairman). Learn More on Sientra's active insiders.

Caroline F. Van Hove Insider Trading History at Sientra

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/10/2021	Sell	608	$56.70	$34,473.60
1/13/2021	Sell	197	$47.10	$9,278.70	14,201

Caroline F. Van Hove Buying and Selling Activity at Sientra

Sientra Company Overview

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Today's Range

Now: N/A

50 Day Range

MA: $0.43

$0.17

$0.68

2 Week Range

Now: N/A

Volume

3,435,100 shs

Average Volume

4,151,154 shs

Market Capitalization

$2.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad